Since the 1920s, it has been recognized that cancer cells exhibit metabolic features that are distinct from those of 'normal' cells. However, a comprehensive picture of cancer metabolism and its molecular underpinnings has been essentially unapproachable—that is, until very recently. With the emergence of effective analytical strategies for broad-based metabolite profiling (both targeted and untargeted), the cancer cell 'metabolome' has now come into sight. Taking advantage of LC-MS-based analytical platforms, the participating speakers will describe new knowledge of metabolic pathways that distinguish cancer cells, signaling cascades that drive cancer-selective metabolic pathways and implications for the development of novel cancer chemotherapies.
The call for poster abstracts is now closed.
|Student / Postdoc / Fellow Member:
|Nonmember Not for Profit:
|Student / Postdoc / Fellow Nonmember: